Search

Your search keyword '"Muhle, Hiltrud"' showing total 619 results

Search Constraints

Start Over You searched for: Author "Muhle, Hiltrud" Remove constraint Author: "Muhle, Hiltrud"
619 results on '"Muhle, Hiltrud"'

Search Results

2. Semantic Similarity Analysis Reveals Robust Gene-Disease Relationships in Developmental and Epileptic Encephalopathies

3. Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals

4. SLC35A2‐CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals

5. Clinical spectrum of STX1B-related epileptic disorders.

7. Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: A multicentre cohort study from Germany

8. Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients’ Perspectives

9. DNM1 encephalopathy

10. DNM1 encephalopathy: A new disease of vesicle fission.

12. A post glycosylphosphatidylinositol (GPI) attachment to proteins, type 2 (PGAP2) variant identified in Mabry syndrome index cases: Molecular genetics of the prototypical inherited GPI disorder

14. Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort study

15. List of Contributors

17. De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies

18. Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study

19. Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial

20. TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants

22. KCNT2-related disorders: phenotypes, functional and pharmacological properties

23. De novo variants in neurodevelopmental disorders with epilepsy

24. KCNT2-Related Disorders:Phenotypes, Functional, and Pharmacological Properties

25. Clinical spectrum of STX1B-related epileptic disorders

27. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Epilepsy Patients With KCNC2 Pathogenic Variants 10.1212/WNL.0000000000200660

28. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants

29. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants.

30. Alterations in the α2δ ligand, thrombospondin‐1, in a rat model of spontaneous absence epilepsy and in patients with idiopathic/genetic generalized epilepsies

31. Neurodevelopmental Disorders Caused by De Novo Variants in KCNB1 Genotypes and Phenotypes

32. Mutations in GABRB3: From febrile seizures to epileptic encephalopathies

33. Correction: TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants

34. Spectrum of Phenotypic, Genetic, and Functional Characteristics in Patients With Epilepsy With KCNC2 Pathogenic Variants

36. The KCNB1 phenotypic and genetic spectrum

37. Four patients with speech delay, seizures and variable corpus callosum thickness sharing a 0.440 Mb deletion in region 1q44 containing the HNRPU gene

38. Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals

39. Distinct gene-set burden patterns underlie common generalized and focal epilepsies

40. The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome

41. Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia

42. Galanin pathogenic mutations in temporal lobe epilepsy

43. Rare variants in γ-aminobutyric acid type A receptor genes in rolandic epilepsy and related syndromes

44. CHD2 variants are a risk factor for photosensitivity in epilepsy

45. Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly

48. De novo FZR1 loss-of-function variants cause developmental and epileptic encephalopathies

49. Heterozygous variants in KCNC2 cause a broad spectrum of epilepsy phenotypes associated with characteristic functional alterations 2021.05.21.21257099

50. Efficacy, tolerability, and retention of fenfluramine for the treatment of seizures in patients with Dravet syndrome: Compassionate use program in Germany

Catalog

Books, media, physical & digital resources